EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples